Samala, Johanika A.

HRN: 02-67-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2023
CEFUROXIME 1.5GM (VIAL)
03/03/2023
03/10/2023
IV
1.5g
Q8hours
UTI
Waiting Final Action 
03/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/03/2023
03/10/2023
IV
500mg
Q8hours
Amoebiasis
Waiting Final Action 
03/04/2023
METRONIDAZOLE 500MG (TAB)
03/04/2023
03/09/2023
PO
500mg
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: